搜索
Antigens
Antigens refer to substances that can stimulate the body to produce (specific) immune responses, and can combine with immune response product antibodies and sensitized lymphocytes in vitro and in vivo to produce immune effects (specific responses).
- Product name
- Catalog NO.
- Source
- Usage
- Platform
- SARS-COV-2 Spike RBD Recombinant Protein-HRP HRCOVS01
- Catalog NO. HRCOVS01
- Source HEK293
- Usage Labeling
- Platform ELISA
- SARS-COV-2 Nucleocapsid Recombinant Protein AGCOVN01
- Catalog NO. AGCOVN01
- Source E.coli
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 Spike RBD-mFc Recombinant Protein AGCOVS03
- Catalog NO. AGCOVS03
- Source HEK293
- Usage Coating
- Platform GICA, FIA, ELISA
- SARS-COV-2 Spike RBD Recombinant Protein AGCOVS01
- Catalog NO. AGCOVS01
- Source HEK293
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 Spike RBD Recombinant Protein AGCOVS02
- Catalog NO. AGCOVS02
- Source HEK293
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 S1 Recombinant Protein (high purity) AGCOVS05
- Catalog NO. AGCOVS05
- Source HEK293
- Usage
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 S1 Recombinant Protein AGCOVS04
- Catalog NO. AGCOVS04
- Source HEK293
- Usage
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 Spike RBD Recombinant Protein-HRP HRCOVS01
- Catalog NO. HRCOVS01
- Source HEK293
- Usage Labeling
- Platform ELISA
- SARS-COV-2 Nucleocapsid Recombinant Protein-HRP HRCOVN01
- Catalog NO. HRCOVN01
- Source E.coli
- Usage Labeling
- Platform ELISA
Previous
1
Next
Shenzhen AIVD Biotechnology Co. , LTD.
A4 Building 4th Floor / B5 Building C501, China Merchants Bright Technology Park, Fenghuang Street, Guangming District, Shenzhen, Guangdong Province, China
E-mail：
market@aivdbiotech.com
info@aivdbiotech.com
Tel： +86-755-26165742 +86 18543132823
WhatsApp：+86 18543132823
© 2022 Shenzhen AIVD Biotechnology Co.,LTD. 粤ICP备18093805号